title: Evidence for cellular protein covalent binding derived from styrene metabolite.
abstract: Styrene is one of the most important industrial intermediates consumed in the world. Human exposure to styrene occurs mainly in the reinforced plastics industry, particularly in developing countries. Styrene has been found to be hepatotoxic and pneumotoxic in humans and animals. The biochemical mechanisms of styrene-induced toxicities remain unknown. Albumin and hemoglobin adduction derived from styrene oxide, a major reactive metabolite of styrene, has been reported in blood samples obtained from styrene-exposed workers. The objectives of the current study focused on cellular protein covalent binding of styrene metabolite and its correlation with cytotoxicity induced by styrene. We found that radioactivity was bound to cellular proteins obtained from mouse airway trees after incubation with (14)C-styrene. Microsomal incubation studies showed that the observed protein covalent binding required the metabolic activation of styrene. The observed radioactivity binding in protein samples obtained from the cultured airways and microsomal incubations was significantly suppressed by co-incubation with disulfiram, a CYP2E1 inhibitor, although disulfiram apparently did not show a protective effect against the cytotoxicity of styrene. A 2-fold increase in radioactivity bound to cellular proteins was detected in cells stably transfected with CYP2E1 compared to the wild-type cells after (14)C-styrene exposure. With the polyclonal antibody developed in our lab, we detected cellular protein adduction derived from styrene oxide at cysteinyl residues in cells treated with styrene. Competitive immunoblot studies confirmed the modification of cysteine residues by styrene oxide. Cell culture studies showed that the styrene-induced protein modification and cell death increased with the increasing concentration of styrene exposure. In conclusion, we detected cellular protein covalent modification by styrene oxide in microsomal incubations, cultured cells, and mouse airways after exposure to styrene and found a good correlation between styrene-induced cytotoxicity and styrene oxide-derived cellular protein adduction.
authors.affiliation: Department of Medicine, University of Washington, Seattle, WA 98195, United States.
authors.forename: Wei
authors.initials: W
authors.lastname: Yuan
authors.forename: Hua
authors.initials: H
authors.lastname: Jin
authors.forename: Jou-Ku
authors.initials: JK
authors.lastname: Chung
authors.forename: Jiang
authors.initials: J
authors.lastname: Zheng
mesh_terms: D000818:Animals; D002460:Cell Line; D019392:Cytochrome P-450 CYP2E1 / Q000378:metabolism; D003603:Cytotoxins / Q000009:adverse effects* / Q000378:metabolism*; D004852:Epoxy Compounds / Q000009:adverse effects / Q000378:metabolism; D006801:Humans; D008297:Male; D051379:Mice; D011485:Protein Binding; D011506:Proteins / Q000378:metabolism*; D020058:Styrene / Q000009:adverse effects* / Q000378:metabolism*
chemical_list: D003603:Cytotoxins; D004852:Epoxy Compounds; D011506:Proteins; D020058:Styrene; C013690:styrene oxide; D019392:Cytochrome P-450 CYP2E1
references.citation: Chem Res Toxicol. 2010 Jan;23(1):251-7
references.pmid: 20020750
references.citation: Int Arch Occup Environ Health. 1998 Feb;71(1):35-41
references.pmid: 9523247
references.citation: J Pharmacol Exp Ther. 1973 Oct;187(1):203-10
references.pmid: 4147720
references.citation: Drug Metab Rev. 2005;37(1):41-213
references.pmid: 15747500
references.citation: Arch Environ Health. 1968 May;16(5):656-62
references.pmid: 5652389
references.citation: Osaka City Med J. 1985 Aug;31(1):11-21
references.pmid: 4094754
references.citation: Crit Rev Toxicol. 1994;24 Suppl:S35-46
references.pmid: 7818770
references.citation: Biochem Biophys Res Commun. 1992 Feb 14;182(3):1348-55
references.pmid: 1540179
references.citation: J Pharmacol Exp Ther. 1973 Oct;187(1):195-202
references.pmid: 4746327
references.citation: Pharmacology. 1974;12(3):129-43
references.pmid: 4445191
references.citation: Fundam Appl Toxicol. 1997 Feb;35(2):152-65
references.pmid: 9038236
references.citation: Chem Res Toxicol. 1996 Mar;9(2):451-6
references.pmid: 8839049
references.citation: J Appl Toxicol. 1986 Dec;6(6):405-12
references.pmid: 3805568
references.citation: Scand J Work Environ Health. 1978;4 Suppl 2:254-8
references.pmid: 734412
references.citation: Carcinogenesis. 1983;4(1):1-3
references.pmid: 6821880
references.citation: Toxicology. 2006 Sep 21;226(2-3):99-106
references.pmid: 16872732
references.citation: Toxicol Appl Pharmacol. 1996 Nov;141(1):299-307
references.pmid: 8917703
references.citation: J Pharmacol Exp Ther. 2010 Mar;332(3):738-46
references.pmid: 20008063
references.citation: Chem Res Toxicol. 2007 Feb;20(2):316-21
references.pmid: 17266334
references.citation: Chem Biol Interact. 2009 Apr 15;179(1):38-44
references.pmid: 18823962
references.citation: Chem Biol Interact. 1995 Mar 30;95(1-2):79-87
references.pmid: 7697755
references.citation: Mutat Res. 1999 Sep 30;445(2):205-24
references.pmid: 10575431
references.citation: Am J Respir Cell Mol Biol. 1996 Jun;14(6):586-98
references.pmid: 8652187
references.citation: Scand J Work Environ Health. 1993 Aug;19(4):255-63
references.pmid: 8235514
references.citation: Proc Natl Acad Sci U S A. 1989 Jan;86(1):322-6
references.pmid: 2911577
references.citation: Cancer Detect Prev. 2003;27(4):275-84
references.pmid: 12893075
references.citation: BMC Chem Biol. 2009 Jun 12;9:5
references.pmid: 19523227
references.citation: Toxicol Sci. 2010 Jun;115(2):589-95
references.pmid: 20176620
references.citation: Adv Pharmacol. 1994;30:199-245
references.pmid: 7833293
references.citation: Environ Mol Mutagen. 1991;17(1):27-31
references.pmid: 1991456
references.citation: Bull Inst Marit Trop Med Gdynia. 1975;26(3-4):299-302
references.pmid: 1203595
references.citation: Chem Res Toxicol. 1992 May-Jun;5(3):406-10
references.pmid: 1504264
references.citation: Toxicology. 2008 Dec 5;254(1-2):1-10
references.pmid: 18951947
references.citation: Crit Rev Toxicol. 1989;19(3):227-49
references.pmid: 2653733
references.citation: Chem Res Toxicol. 1999 Sep;12(9):831-9
references.pmid: 10490505
references.citation: Mol Pharmacol. 1996 Sep;50(3):573-82
references.pmid: 8794896
references.citation: Proc Natl Acad Sci U S A. 1971 Jan;68(1):160-4
references.pmid: 4395686
references.citation: Toxicol Appl Pharmacol. 1973 Feb;24(2):279-97
references.pmid: 4696311
references.citation: Mutat Res. 1980 Dec;73(2):387-401
references.pmid: 7464847
references.citation: Toxicol Appl Pharmacol. 1997 Oct;146(2):317-27
references.pmid: 9344900
references.citation: Chem Res Toxicol. 1996 Oct-Nov;9(7):1159-66
references.pmid: 8902272
references.citation: Mutat Res. 2001 Oct 1;482(1-2):89-103
references.pmid: 11535253
references.citation: J Appl Toxicol. 2001 May-Jun;21(3):185-98
references.pmid: 11404830
references.citation: Toxicol Appl Pharmacol. 2000 Oct 1;168(1):36-49
references.pmid: 11000098
references.citation: Xenobiotica. 1997 Jan;27(1):101-10
references.pmid: 9041682
references.citation: Clin Chim Acta. 2006 Mar;365(1-2):9-29
references.pmid: 16199025
references.citation: Arch Toxicol Suppl. 1986;9:286-90
references.pmid: 3468906
references.citation: Annu Rev Pharmacol Toxicol. 1997;37:91-117
references.pmid: 9131248
references.citation: Toxicol Sci. 1998 Dec;46(2):266-81
references.pmid: 10048130
references.citation: Drug Metab Rev. 1993;25(4):395-451
references.pmid: 8313837
references.citation: Chem Res Toxicol. 1991 Mar-Apr;4(2):168-79
references.pmid: 1664256